Thus, the results obtained from the gain-of-function and loss-of-function experiments clearly suggested a tumor-suppressor role of A20 in HCC, which was consistent with previous findings in lymphomas [7, 8, 39]. This evidence concerns the gene TNFAIP3 and hepatocellular carcinoma.